JP Morgan Chase
WX

JP Morgan Chase’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

JP Morgan Chase’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-27,000
Closed -$1.17M – 4947
2015
Q3 		$1.17M Hold
27,000
– – ﹤0.01% 3031
2015
Q2 		$1.14M Buy
+27,000
New +$1.14M ﹤0.01% 3220

Other funds holding WX

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CCS
Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

JP Morgan Chase's WX Position: Q4 2015 in Review

JP Morgan Chase sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 10,342 shares — an estimated $447K sold.

JP Morgan Chase first reported a position in WX in Q2 2013 and held it in 10 quarters. The position peaked at $72.4M in Q3 2013. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

  • JP Morgan Chase reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
  • JP Morgan Chase sold 10,342 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $447K.
  • JP Morgan Chase first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 10 quarters.
  • JP Morgan Chase's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $72.4M in Q3 2013.
  • 2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on JP Morgan Chase's 13F filing for Q4 2015, filed 12 Feb 2016.